Form 4: Perrigo EVP Alison Ives Reports Stock Transactions
SEC Form 4
Alison Ives, EVP & Chief Scientific Officer of Perrigo Co. plc, reports acquisition and disposal of ordinary shares and restricted stock units.
Summary
- Alison Ives, EVP & Chief Scientific Officer of Perrigo Co. plc, filed a Form 4 detailing changes in beneficial ownership.
- On March 6, 2024, Ives acquired 2,030 ordinary shares at $28.09 and disposed of 612 shares at $28.09.
- On March 7, 2024, Ives acquired 1,746 ordinary shares at $29.69 and disposed of 526 shares at $29.69.
- These transactions involved the exercise of restricted stock units, each representing a contingent right to receive one Perrigo Company plc ordinary share.
- Following these transactions, Ives beneficially owns 18,010 ordinary shares and 1,746 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives.
- Companies like Teva, Mylan (now Viatris), and Johnson & Johnson also have executives who regularly file Form 4s to report their transactions in company stock.
- The reporting requirements are governed by Section 16(a) of the Securities Exchange Act of 1934.
Stakeholder Impact
- The transactions may have a minor impact on shareholders as they reflect insider trading activity.
- The filing ensures transparency for shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 05/25/2022 | Date of Power of Attorney execution. |
| 03/06/2024 | Acquisition of 2,030 ordinary shares at $28.09 and disposal of 612 shares at $28.09. |
| 03/06/2024 | Vesting of Restricted Stock Units beginning. |
| 03/07/2024 | Acquisition of 1,746 ordinary shares at $29.69 and disposal of 526 shares at $29.69. |
| 03/08/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.